Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.14670/HH-18-438

Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorGong, Lihua-
dc.contributor.authorSun, Xiaoqi-
dc.contributor.authorZhang, Ming-
dc.contributor.authorDu, Junbao-
dc.contributor.authorDing, Yi-
dc.contributor.authorJin, Hongfang-
dc.date.accessioned2023-02-24T10:18:23Z-
dc.date.available2023-02-24T10:18:23Z-
dc.date.issued2022-
dc.identifier.citationHistology and Histopathology Vol. 37, nº7 (2022)es
dc.identifier.issn0213-3911-
dc.identifier.issn1699-5848-
dc.identifier.urihttp://hdl.handle.net/10201/128746-
dc.description.abstractBackground. Hydrogen sulfide (H2S) is a novel gas transmitter signaling molecule. H2S is synthesized by cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (MST). There have been no reports about the roles of these enzymes in osteosarcoma and its metastases. We detected H2S synthase expression levels in human primary osteosarcoma and lung metastatic osteosarcoma. Methods. Immunohistochemistry was performed in primary osteosarcoma (n=19), lung metastatic osteosarcoma (n=11), osteoblastoma (n=10) and bony callus (n=2). The expression of CBS, CSE, and MST was defined as negative, moderately positive and strongly positive. Results. MST staining was moderately to strongly positive in all cases. CSE staining was negative in 94.7% (18/19) of primary osteosarcoma cases and 90.9% (10/11) of lung metastatic osteosarcoma cases. CBS staining was strongly positive in 68.4% (13/19) of primary osteosarcoma cases, moderately positive in 15.8% (3/19) of cases, and negative in 15.8% (3/19) of cases. In lung metastatic osteosarcoma, the proportions of negative, moderately positive and strongly positive cases were 63.6% (7/11), 18.2% (2/11) and 18.2% (2/11), respectively. Conclusions. CBS and CSE expression, especially CSE expression, decreased in both primary osteosarcoma and lung metastatic osteosarcoma, which may suggest that CBS and CSE play roles in osteoblast cell malignant transformation and osteosarcoma progression. These enzymes could be used as new prognostic assessment factors and may represent new therapeutic targets for osteosarcoma and metastasis preventiones
dc.formatapplication/pdfes
dc.format.extent7es
dc.languageenges
dc.publisherUniversidad de Murcia, Departamento de Biologia Celular e Histiologiaes
dc.relationSin financiación externa a la Universidades
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHydrogen sulfidees
dc.subjectOsteosarcomaes
dc.subjectMetastaseses
dc.subjectCystathionine β-synthasees
dc.subjectCystathionine γlyasees
dc.subject3 mercaptopyruvate sulfurtransferasees
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncologíaes
dc.titleThe expression of hydrogen sulfide-producing enzymes in primary and lung metastatic osteosarcomaes
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doihttps://doi.org/10.14670/HH-18-438-
Aparece en las colecciones:Vol.37, nº7 (2022)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Gong-37-709-715-2022.pdf9,54 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons